112 related articles for article (PubMed ID: 10575652)
1. Effects of disease on expression and regulation of CYPs.
Farrell G
Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652
[No Abstract] [Full Text] [Related]
2. Posttranscriptional elevation of cytochrome P450 3A expression.
Zangar RC; Hernandez M; Novak RF
Biochem Biophys Res Commun; 1997 Feb; 231(1):203-5. PubMed ID: 9070249
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of the expression and modulation of CYP3A gene].
Wang JS; Zhou HH
Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
[No Abstract] [Full Text] [Related]
4. A novel female-specific member of the CYP3A gene subfamily in the mouse liver.
Sakuma T; Takai M; Endo Y; Kuroiwa M; Ohara A; Jarukamjorn K; Honma R; Nemoto N
Arch Biochem Biophys; 2000 May; 377(1):153-62. PubMed ID: 10775455
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?
Wauthier V; Verbeeck RK; Buc Calderon P
Arch Toxicol; 2004 Mar; 78(3):131-8. PubMed ID: 14600803
[TBL] [Abstract][Full Text] [Related]
6. Genetics. SNP-ing drugs to size.
Gura T
Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
[No Abstract] [Full Text] [Related]
7. Cyp3A regulation: from pharmacology to nuclear receptors.
Quattrochi LC; Guzelian PS
Drug Metab Dispos; 2001 May; 29(5):615-22. PubMed ID: 11302925
[TBL] [Abstract][Full Text] [Related]
8. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization.
Chiou WL; Jeong HY; Wu TC; Ma C
Clin Pharmacol Ther; 2001 Oct; 70(4):305-10. PubMed ID: 11673745
[No Abstract] [Full Text] [Related]
9. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
Liangpunsakul S; Kolwankar D; Pinto A; Gorski JC; Hall SD; Chalasani N
Hepatology; 2005 May; 41(5):1144-50. PubMed ID: 15841467
[TBL] [Abstract][Full Text] [Related]
10. Identification and hepatic expression profiles of cytochrome P450 1-4 isozymes in common minke whales (Balaenoptera acutorostrata).
Niimi S; Kim EY; Iwata H; Watanabe MX; Yasunaga G; Fujise Y; Tanabe S
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):667-81. PubMed ID: 17526421
[TBL] [Abstract][Full Text] [Related]
11. CYP3A genetics in drug metabolism.
Eichelbaum M; Burk O
Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
[No Abstract] [Full Text] [Related]
12. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR.
Zhang J; Huang W; Chua SS; Wei P; Moore DD
Science; 2002 Oct; 298(5592):422-4. PubMed ID: 12376703
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
[TBL] [Abstract][Full Text] [Related]
14. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response.
Beigneux AP; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
Biochem Biophys Res Commun; 2002 Apr; 293(1):145-9. PubMed ID: 12054576
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization and differential expression of cytochrome P450 3A27 in the gastrointestinal tract of rainbow trout.
Lee SJ; Hedstrom OR; Fischer K; Wang-Buhler JL; Sen A; Cok I; Buhler DR
Toxicol Appl Pharmacol; 2001 Dec; 177(2):94-102. PubMed ID: 11740908
[TBL] [Abstract][Full Text] [Related]
16. Identification, characterization, and ontogeny of a second cytochrome P450 3A gene from the fresh water teleost medaka (Oryzias latipes).
Kullman SW; Hinton DE
Mol Reprod Dev; 2001 Feb; 58(2):149-58. PubMed ID: 11139226
[TBL] [Abstract][Full Text] [Related]
17. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.
Niemelä O; Parkkila S; Juvonen RO; Viitala K; Gelboin HV; Pasanen M
J Hepatol; 2000 Dec; 33(6):893-901. PubMed ID: 11131450
[TBL] [Abstract][Full Text] [Related]
18. Thin-layer chromatographic analysis of human CYP3A-catalyzed testosterone 6 beta-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 1998; 107():153-61. PubMed ID: 14577225
[No Abstract] [Full Text] [Related]
19. Nuclear xeno-sensors as receptors for cholestatic bile acids: the second line of defense.
Bock HH; Lammert F
Hepatology; 2002 Jan; 35(1):232-4. PubMed ID: 11786981
[No Abstract] [Full Text] [Related]
20. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.
Schuetz EG; Umbenhauer DR; Yasuda K; Brimer C; Nguyen L; Relling MV; Schuetz JD; Schinkel AH
Mol Pharmacol; 2000 Jan; 57(1):188-97. PubMed ID: 10617694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
